# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Glioblastoma

GBMGlioblastoma multiforme
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 359 results.
Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
Status: Recruiting
Last Changed: Jun 18, 2019
First Received: Sep 07, 2018
Disease(s): Glioblastoma
Intervention(s): Pembrolizumab, Bevacizumab, Re-irradiation
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Columbia University / Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States
... and 1 other locations.
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Status: Recruiting
Last Changed: Feb 26, 2020
First Received: Nov 30, 2016
Disease(s): Glioblastoma
Intervention(s): Temozolomide, Neratinib, CC-115, Abemaciclib
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Columbia University Medical Center, New York, New York, United States
... and 8 other locations.
TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
Status: Not yet recruiting
Last Changed: Feb 05, 2020
First Received: May 18, 2018
Disease(s): Glioblastoma
Intervention(s): TN-TC11G, Temozolomide Oral Product, Radiotherapy
Locations: Institut Català d'Oncología L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario Son Espases, Palma de Mallorca, Mallorca, Spain
Consorcio Hospitalario Provincial de Castellón, Castelló, Valencia, Spain
Hospital del Mar, Barcelona, Spain
Complejo Hospitalario Regional Virgen de las Nieves, Granada, Spain
... and 4 other locations.
Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
Status: Recruiting
Last Changed: Apr 04, 2019
First Received: Aug 09, 2017
Disease(s): Glioblastoma
Intervention(s): Temozolomide+Metformin, Temozolomide+Placebo
Locations: National Cancer Center Korea, Ilsan, Gyeonggi-Do, Korea, Republic of
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-Do, Korea, Republic of
Ajou University Hospital, Suwon-si, Gyeonggi-Do, Korea, Republic of
Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-Do, Korea, Republic of
Incheon St. Mary's Hospital, Incheon, Korea, Republic of
... and 8 other locations.
Abemaciclib + Pembrolizumab In Glioblastoma
Status: Not yet recruiting
Last Changed: Jan 29, 2020
First Received: Oct 07, 2019
Disease(s): Glioblastoma
Intervention(s): Pembrolizumab, Abemaciclib
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
Status: Recruiting
Last Changed: Jul 02, 2019
First Received: Jul 02, 2019
Disease(s): Recurrent Glioblastoma
Intervention(s): Anlotinib
Locations: Shandong cancer hospital, Jinan, Shandong, China
Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Status: Recruiting
Last Changed: Jul 24, 2019
First Received: Dec 01, 2015
Disease(s): Glioblastoma
Intervention(s): Platelet level determination
Locations: Centre Henri Becquerel, Rouen, France
Trial of Combination TTF(Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma
Status: Recruiting
Last Changed: Nov 19, 2019
First Received: Feb 13, 2018
Disease(s): Recurrent Glioblastoma
Intervention(s): Nivolumab 240 mg IV, Nivolumab 3 mg/kg, Ipilimumab 1 mg/kg, NovoTTF200A (Optune)
Locations: Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Status: Recruiting
Last Changed: Jan 23, 2019
First Received: Feb 19, 2016
Disease(s): Glioblastoma
Intervention(s): Standard surgery (neuronavigation-guided), Intraoperative radiotherapy, Radiochemotherapy, Temozolomide
Locations: Barrow Neurological Institute (SJHMC), Phoenix, Arizona, United States
Stritch School of Medicine Loyola University, Maywood, Illinois, United States
Long Island Jewish Medical Center, North Shore University Hospital, Lake Success, New York, United States
Lenox Hill Hospital, Hofstra Northwell School of Medicine, New York, New York, United States
West Virginia University, Morgantown, West Virginia, United States
... and 8 other locations.
Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
Status: Recruiting
Last Changed: May 31, 2019
First Received: Mar 15, 2018
Disease(s): Glioblastoma
Intervention(s): PF-04449913, Temozolomide Oral Capsule
Locations: Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Institut Catalá de Oncología Girona/Hospital Universitari Dr. Josep Trueta, Girona, Spain
Hospital Universitario Ramón y Cajal, Madrid, Spain
Hospital Universitario y Politécnico La Fe, Valencia, Spain